Schedule 13G ownership disclosure

ALLOVIR INC

Security class unavailable · CUSIP: 019818103

Event date: 2020-12-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.6900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-002531
Form type
SC 13G/A
Filer
Kalaris Therapeutics, Inc.
CIK
CIK 1754068
Filed
Jan 09, 2024
Reporting period
Dec 16, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub